Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World Study.

导出原文传递

翻译打印收藏纠错

作者： Eric,François ^[1] ; Laurent,Mineur ^[2] ; Gaël,Deplanque ^[3] ; Philippe,Laplaige ^[4] ; Denis,Smith ^[5] ; Sophie,Gourgou ^[6] ; Alexandre,Tanang ^[7] ; Miruna,Ionescu-Goga ^[7] ; Kalaivani,Veerabudun ^[8] ; Yoann,Lelarge ^[7] ; Stefano,Kim ^[9] ; Florence,Rollot ^[10]

作者单位： Oncologie médicale, Centre Antoine Lacassagne, Nice, France. Electronic address: eric.francois@nice.unicancer.fr. ^[1] Radiation Oncology, Gastro-Intestinal and Liver Cancer Unit, Institut Sainte-Catherine, Avignon, France. ^[2] Oncologie médicale, Groupe hospitalier Paris Saint Joseph, Paris, France. ^[3] Oncologie et chimiothérapie ambulatoire, Polyclinique de Blois, La Chaussée St Victor, France. ^[4] Hépato-gastro-entérologie, Hôpital Saint André, Bordeaux, France. ^[5] Unité de Biométrie, Institut du Cancer de Montpellier, Montpellier, France. ^[6] Medical Department, Oncology, Roche SAS, Boulogne Billancourt, France. ^[7] Roche Medical Department, Oncology, Aixial R&D, Boulogne Billancourt, France. ^[8] Oncologie médicale, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France. ^[9] Soins de support en oncologie/onco-gériatrie, Institut Curie, Paris, France. ^[10]

关键词 Aged Bevacizumab Colorectal neoplasms Neoplasm metastasis Observational study